AUROBINDO PHARMA FDA Approval ANDA 215124

ANDA 215124

AUROBINDO PHARMA

FDA Drug Application

Application #215124

Application Sponsors

ANDA 215124AUROBINDO PHARMA

Marketing Status

Prescription001

Application Products

001FOR SOLUTION;ORAL50MG/ML0VALGANCICLOVIR HYDROCHLORIDEVALGANCICLOVIR HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2022-11-17STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

AUROBINDO PHARMA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 215124
            [companyName] => AUROBINDO PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"VALGANCICLOVIR HYDROCHLORIDE","activeIngredients":"VALGANCICLOVIR HYDROCHLORIDE","strength":"50MG\/ML","dosageForm":"FOR SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/17\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-11-17
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.